R NA-binding proteins are central regulators of gene expression in both health and disease. 1, 2 The RNA-binding protein Quaking (QKI) is a member of the highly conserved signal transduction and activator of RNA (STAR) family of RNA-binding proteins. 3 Alternative splicing of the mammalian qkI transcript yields 3 protein isoforms, notably QKI-5, QKI-6, and QKI-7, 2 with dimerization of QKI isoforms being required for the regulation of pre-mRNA splicing, mRNA export, and stability. 2,4 QKI drives central and peripheral nervous system myelination by regulating oligodendrocyte and Schwann cell differentiation, respectively. 2,4,5 However, a role for QKI outside the neural network is poorly understood.
QKI has been proposed to regulate processes outside the nervous system because of its ubiquitous expression profile 2 and capacity to impact the processing of many RNA species by binding to quaking response elements (qre's). 5, 6 Importantly, QkI null mice are embryonic-lethal because of an inability of immature mural cells to migrate and differentiate into vascular smooth muscle cells (VSMCs) effectively, resulting in perturbed investment and stabilization of nascent vessels in the yolk sac vasculature. [7] [8] [9] In adults, VSMCs of the artery wall contract and provide vascular tone. 10 However, in response to vascular injury, VSMCs can dedifferentiate from a contractile to a synthetic state. 10, 11 The unabated expansion of VSMCs can lead to pathophysiologic complications, such as clinical restenosis after percutaneous coronary intervention, 12, 13 arteriovenous shunt failure, 14, 15 and transplant vasculopathy. 16 Generally, VSMCs are programmed to avoid this excessive reparative response, because they possess the capacity to sense and respond to extracellular and intracellular cues that trigger the reversion to the contractile phenotype.
The transcriptional coactivator Myocardin (Myocd) is a primary driver of this redifferentiation process, 17 because interaction with serum response factor (SRF) at CArGbox-containing promoters [18] [19] [20] activates contractile apparatus protein expression that is required for physiological VSMC functioning. 21, 22 Given that QKI is a regulator of embryonic vascular development, we sought to determine the role of QKI in the adult vasculature. Here, we show that the RNA-binding protein QKI is a critical regulator of VSMC phenotype by binding to and regulating Myocd expression and alternative splicing, implicating a critical role for QKI in the regulation of physiological VSMC function and vascular repair.
Methods

Human Studies
Coronary atherectomy specimens were obtained from a cohort of patients that underwent elective directional coronary atherectomy of the target vessel 3 to 6 months after percutaneous transluminal coronary angioplasty 23 and immunohistochemically stained for QKI using a mouse monoclonal antihuman pan-QKI antibody (clone N147/6; UC Davis/NIH NeuroMab Facility) and smooth muscle α-actin (ACTA2; clone 1A4; Sigma-Aldrich, Zwijndrecht, the Netherlands). Antibody binding was visualized with NovaRED and Vector Blue substrates (Vector Laboratories, Burlingame, CA). Human cortex cryosections were used as an isotype and reference control. Methylene green was used as counterstain.
Animal Studies
Female Quaking viable (Qk v ) mice on a C57/Bl6-J background together with age-and sex-matched C57Bl6-J wild-type (WT) mice (Jackson Laboratories, Bar Harbor, ME) were sheathed with a nonconstrictive cuff as previously described. 24 Immunohistochemical analysis and quantitation of femoral arteries was performed as described previously. 25 Incorporation of 5-bromo-2-deoxyuridine (BrdU) into DNA as a marker of DNA synthesis was studied by intraperitoneal BrdU injection (100 mg/kg) 72, 48, and 24 hours before euthanasia. QKI was detected using a rabbit polyclonal antihuman QKI antibody (N20; Santa Cruz Biotechnology, CA). Transluminal wire injury of the left common carotid artery was performed in female apoE −/− fed a Western-type diet as previously described. 26 Uninjured arteries (day 0) and wire-injured arteries were harvested at days 1, 3, 7, 14, 21, and 28. All animal work was approved by the regulatory authorities of the Leiden University and was in compliance with the Dutch government guidelines.
VSMC Isolation and Culture
Aortic explants harvested from WT and Qk v mice were cultured in DMEM containing 10% FCS and 0.01 μg/mL glutamine at 37°C and 5% CO 2 . The human internal thoracic (HITC6 and HITA2) clonal cell lines were generated and cultured as previously described. 21, 27 The Material and Methods section in the Online Data Supplement details cloning strategies and construction of vectors used for luciferase (pMIR-REPORT), splicing, and lentiviral overexpression of Myocd. Primary mouse and human VSMCs were stably transduced using lentiviral shRNA that specifically target qkI or using a scrambled control shRNA (MISSION library; Sigma-Aldrich). Stable transductants were selected with 3 µg/mL puromycin for 72 hours. Clonal HITA2 subpopulations were scored microscopically and expanded for experiments.
Collagen Production Assay
Primary WT and Qk v mouseVSMCs and HITC6 VSMCs were seeded at a density of 1.5×10 4 cells/cm 2 , extensively washed with PBS and fixed for 30 minutes using Formafix (Thermo Scientific, Waltham, MA). Cellular collagen production was assessed by staining with Sirius Red F3B dye and concentrations determined spectrometrically at 550 nm.
DNA Synthesis and Cellular Migration Assays
DNA synthesis and cellular migration of VSMCs derived from WT and Qk v aortas and HITC6 VSMCs were performed as previously described. 28
Western Blot Analysis
Proteins were resolved by polyacrylamide electrophoresis. Primary antibodies used to detect QKI-5, QKI-6, and QKI-7 were either rabbit polyclonal (EMD Millipore, Amsterdam, the Netherlands) or mouse monoclonal antibodies that specifically target QKI-5 (N195A/16), QKI-6 (N182/17), or QKI-7 (N183/15.1; UC Davis/NIH NeuroMab Facility). Mouse monoclonal antibodies were used to detect ACTA2 (clone 1A4; R&D Systems, Leiden, the Netherlands), calponin (CNN1; hCP; Sigma-Aldrich), caldesmon (CALD1; clone hHCD; Sigma-Aldrich), and smoothelin (SMTN; kindly provided by Dr G. van Eys, Maastricht University Medical Center). Hemagglutinintagged Myocd protein was detected using a monoclonal antimouse HA.11 antibody (clone 16B12). As a reference, a mouse monoclonal antibody was used to detect α-tubulin (clone DM1A; Sigma-Aldrich), whereas a rabbit polyclonal antibody was used to detect β-actin (Abcam, Cambridge, United Kingdom).
Functional Assessment of VSMC Contractility
To identify single contractile cells, stably transduced sh-cont and sh-qkI HITA2 VSMCs or VSMCs overexpressing enhanced green fluorescent protein (EGFP), MYOCD-v1a, MYOCD-v1b, MYOCD-v3a, or MYOCD-v3b were seeded on deformable silicone substrates (stiffness 5 kPa; Excellness Biotech, Lausanne, Switzerland) 29 in M199 culture medium containing 1% FCS. Cells were seeded onto substrates coated with 10 µg/mL fibronectin isolated from human plasma. Twenty-four hours after seeding, 10 random fields were photographed using phase contrast microscopy 
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RNA Immunoprecipitation
RNA was isolated from HITA2 VSMCs as per manufacturer instructions using the Magna-RIP kit (EMD Millipore) using either goat antirabbit IgG antibody (control) or the IP-validated goat antirabbit QKI-5 antibody (EMD Millipore).
Quantitation of mRNA and Alternative Transcript Generation
Generally, mouse and human cDNA was made using Oligo-dT primers (Invitrogen). For immunoprecipitation and alternative transcript studies, cDNA was generated using random primers (Invitrogen). qRT-PCR analysis for designated mRNA products was performed using SYBR Green master mix (Bio-Rad) in combination with primer combinations described in Online Table I .
Statistics
For all experiments, N defines the number of biological replicates. All image quantitation was performed using Image J software, and results of Western blot and PCR quantitation are provided beneath the images. All in vitro and in vivo results were analyzed using either Student t test or ANOVA (with Tukey, Bonferonni, or Kruskal-Wallis post-test being used when appropriate). Results are expressed as mean±SE or mean +/-SE, as indicated. Differences in probability values <0.05 were considered significant, where degree of significance is indicated as follows: *P<0.05, **P<0.01, ***P<0.001, #P<0.0001. Quantitation of semiquantitative PCR and Western blots are provided in Online Table II .
Results
QKI Is Highly Expressed in VSMCs of Human Restenotic Lesions
Despite the developmental defects observed in the vasculature of QkI-deficient embryos, [7] [8] [9] no studies to date have investigated a role for this RNA-binding protein in VSMCs of the adult vasculature. Therefore, we assessed the levels of QKI expression in human healthy and restenotic atherectomy specimens immunohistochemically. In healthy tissue, QKI was virtually undetectable and confined to the endothelium ( Figure 1A and 1C; n=4 subjects). In contrast, the VSMCs in the neointimal portion of restenotic tissue revealed a profound increase in QKI expression, with a few inflammatory foci also staining positive for QKI ( Figure 1B and 1D; n=5 subjects). Restenotic lesions displayed overt fibrosclerotic morphology with incidental foci of stellate VSMC and myxoid matrix, characteristic of young, restenotic tissue. Costaining of coronary artery lesions for QKI and ACTA2 confirmed that VSMCs are the major QKI-expressing cell type in restenotic lesions ( Figure 1E and 1F). Of note, the pan-QKI antibody exhibited its characteristic punctate intracellular staining pattern in human brain tissue ( Figure 1G and 1H). These studies indicate that QKI is differentially expressed between contractile and proliferative VSMCs and suggest that QKI protein levels could regulate the hyperplastic response to vascular injury.
Qk v Mice Display Reduced Neointima Formation After Femoral Cuff Placement
To determine if QKI is indeed a regulator of vascular remodeling, we first assessed the mRNA and protein expression profile of QKI using an arterial hyperplastic model that induces a VSMC-mediated fibroproliferative response in femoral arteries of C57BL6 (WT) mice. QkI mRNA expression levels decreased immediately after nonconstrictive cuff placement, followed by a significant increase after 3 days and peak QkI mRNA expression 7 days postinjury ( Figure 2A ; n=6 mice per time point; *P<0.05, ***P<0.001), coinciding with the proliferative peak of VSMCs in vascular injury models. 30 Furthermore, we also assessed the temporal expression profile of QkI-5, QkI-6, and QkI-7 mRNA after cuff placement in apoE -/mice (n=4 mice per time point). These studies revealed that QkI-5 and QkI-6 mRNA are markedly increased at day 7 (QkI-6; P<0.05), whereas QkI-7 mRNA levels were consistently decreased in expression (Online Figure IA) . Similar to the mRNA profile, medial layer VSMCs displayed maximally increased QKI protein expression 7 days after femoral cuff placement ( Figure 2B and Online Figure IB ). Interestingly, QkI mRNA levels are significantly downregulated 14 days after cuff placement ( Figure 2A ). Next, we sought to determine if a reduction in QKI expression could impact neointima formation after femoral Figure 2J ; n=6 mice; P=0.42) of cuffed portions of WT and Qk v femoral arteries was similar. We did not observe differences in lesional apoptosis (TUNEL staining), collagen, and CD45 + leukocyte content (data not shown). Collectively, these studies demonstrate that a reduction in QKI expression in vivo decreases neointima formation after vascular injury.
VSMCs Derived From Qk v Mice Display Decreased Proliferation, Migration, and ECM Production
To further assess the functional consequences of abrogated QKI in adult VSMCs, we isolated primary VSMCs from WT and Qk v aortas. After 7 days, VSMC outgrowth was 1.8-fold reduced for Qk v versus WT ( Figure 3A [left] and 3B; n=6 mice with 6-7 pieces of tissue per aorta; P<0.001). Additionally, Qk v VSMCs displayed a 3.5-fold decrease in cellular proliferation ( Figure 3C ; n=6 mice; P<0.01), a 2.0-fold decrease in collagen production ( Figure 3D ; n=4 mice; P<0.05), and a 3.0-fold decrease in transwell migration ( Figure 3E ; n=4 mice; P<0.01) as compared with WT VSMCs. These findings were validated in human VSMCs derived from the human internal thoracic artery (designated HITC6) after lentiviral shRNA-mediated reduction of QKI (sh-cont and sh-qkI), resulting in a 5.7-fold decrease in proliferation ( Figure 3F ; n=3 transductions; P<0.05), a 3.6-fold decrease in collagen production ( Figure 3G ; n=3 transductions; P<0.01), and a 3.1fold decrease in migration ( Figure 3H ; n=3 transductions; P<0.01). These findings show that the reductions in VSMC proliferation, migration, and collagen production observed in Qk v mice can be attributed to decreased QKI expression. Altogether, these data point to a significant role for QKI in regulating functions associated with dedifferentiated VSMCs. 
QKI Expression Levels Impact VSMC Phenotype
Our identification that QKI expression levels impact fibroproliferative properties of VSMCs suggests that QKI could play a role in regulating VSMC phenotype. Therefore, we investigated if the abrogation of QKI could drive synthetic VSMCs to the contractile state. For this, we assessed the mRNA expression profile of contractile apparatus proteins in serially passaged, aorta-derived VSMCs from WT and Qk v mice. As shown in Figure 4A , significantly higher levels of Acta2, smooth muscle myosin heavy chain (Myh11), and Cnn1 mRNAs were expressed in VSMCs derived from Qk v as compared with WT mice (n=6 mice; *P<0.05, **P<0.01).
In contrast, the mRNA levels of smoothelin A (SmtnA) and SmtnB were unaltered ( Figure 4B ; n=6 mice; SmtnA, P=0.42; SmtnB, P=0.45). Western blot analyses of cellular lysates harvested from WT and Qk v aortic VSMCs revealed that a decrease in QKI expression yields increased ACTA2 levels ( Figure 4B ; n=5 mice; P<0.05). Interestingly, we did not observe any changes in the mRNA levels of contractile apparatus proteins harvested from snap-frozen aortas of WT and Qk v mice (data not shown). Next, we verified that decreased QKI expression is coupled with a global increase in contractile apparatus protein expression using HITC6 VSMCs. Western blot analysis of lysates harvested from sh-qkI HITC6 VSMCs showed a potent stimulation of ACTA2, CNN1, and the heavy isoform of CALD1 protein expression as compared with shcont HITC6 VSMCs ( Figure 4C ; n=3 biological replicates; quantitation provided beneath respective Western blots),
whereas the levels of SMTN were unchanged ( Figure 4C ; n=3 biological replicates). Further proof that QKI expression levels play a role in regulating VSMC phenotype was derived from the fact that HITA2 VSMCs, a constitutively proliferative clonal cell population that poorly expresses contractile apparatus proteins, 27 expressed significantly higher levels of all 3 QKI isoforms as compared with HITC6 VSMCs ( Figure 4D ). Interestingly, the forced reduction of QKI shifted HITA2 VSMCs from a rhomboid to an elongated state ( Figure 4E ) and was associated with increased expression of contractile apparatus mRNAs and protein ( Figure 4E and 4F, respectively). We also observed an association between QKI expression levels and VSMC morphology, because clonally expanded cuboidal VSMCs expressed significantly higher levels of QKI than spindle-shaped VSMCs (Online Figure IIA) .
Moreover, we also tested if QKI levels could impact contractile function by seeding sh-cont and sh-qkI HITA2 VSMCs on a silicone elastomere substrate, where cell contractile forces induce deformations that are visible as wrinkles under a phase contrast microscope. As shown in Figure 4G , sh-cont HITA2 VSMCs were incapable of contracting the elastomere substrate, whereas 77% of sh-qkI HITA2 VSMCs acquired the capacity to contract the elastomere substrate functionally ( Figure 4G ; n=3 biological replicates; ***P<0.001). Collectively, these findings strongly suggest that a reduction in QKI protein levels shifts VSMCs to the contractile phenotype. 
QKI Modulates Myocd Expression and Alternative Splicing
VSMC maturation is largely dependent on the interaction of SRF with the transcriptional coactivator Myocd at CArGboxes in the promoters of contractile apparatus proteins. 18, 19 Because attenuation of QKI was associated with increased contractile apparatus protein expression, we investigated whether QKI levels could impact Myocd expression. We found that Myocd mRNA expression was significantly increased in both Qk v and sh-qkI HITC6 VSMCs ( Figure 5A) Next, we tested whether overexpression of QKI in human VSMCs could impact Myocd mRNA expression levels. For this, we stably transduced HITA2 VSMCs with QKI-5, QKI-6, or QKI-7. These studies revealed positive and negative feedback loops among the distinct QKI isoforms ( Figure 5B ; left), and that QKI-6 overexpression significantly attenuates the expression of Myocd mRNA ( Figure 5B ; right; n=3 transductions; P<0.05).
Although previous in silico analyses identified a qre in the 3-′UTR of the Myocd mRNA, 6 our assessment of the Myocd pre-mRNA uncovered 3 qre's that are conserved between mice and human, namely a coding sequence qre (qre-1), as well as 2 3′-UTR qre's (qre-2 and qre-3; Figure 5C ). This led us to investigate whether QKI could bind to the Myocd (pre)-mRNA transcript. Therefore, we performed RNA immunoprecipitation of QKI isoforms in HITA2 using anti-QKI-5 antibody. Indeed, QKI was found to bind to the Myocd (pre)-mRNA 5.1-fold more effectively than an anti-IgG control ( Figure 5D and 5E; n=3 separate IPs; P<0.05). However, luciferase reporter experiments revealed no regulation of QKI at the qre's in the Myocd 3′-UTR (Online Figure IIIA and IIIB) .
Therefore, we focused our attention on qre-1 in the Myocd coding region. Importantly, this qre is located at a critical junction of the Myocd pre-mRNA, namely the 3′-splice site of an alternative exon termed exon 2a ( Figure 5C ). Moreover, QKI has recently been shown to regulate alternative splicing events globally in myotubes by binding proximally to exon-intron boundries. 36 Interestingly, the inclusion of exon 2a introduces a premature stop codon into the mature Myocd transcript (termed Myocd_v3). The subsequent use of a downstream ATG leads to the generation of an 856-amino acid MYOCD_v3 isoform that is greatly enriched in VSMCs as compared with cardiac or skeletal muscle. 20, 31 Surprisingly, HITA2 VSMCs immunostained for QKI-5, QKI-6, and QKI-7 revealed that QKI-6 colocalized with spliceosomal proteins in the cellular nucleus ( Figure 5F ). Next, we tested if the abrogation of QKI protein could influence Myocd_v3 expression levels. For this, we assessed the mRNA levels of Myocd_v3 in explanted aortic VSMCs derived from WT and Qk v mice ( Figure 5G and Online Figure  IIB) . WT aortic VSMCs exclusively expressed Myocd_v1 after serial passaging ( Figure 5G ; quantitation shown below PCR), whereas Qk v VSMCs retained 30.9% exon 2a inclusion (Myocd_v3; n=4 biological replicates; P<0.05). This association between a reduction in QKI expression and enriched exon 2a inclusion was validated in sh-qkI HITA2 VSMCs (6.8-fold versus sh-cont; n=3 transductions; P<0.05) and spindle HITA2 VSMC (3.8-fold versus cuboidal; n=3; P<0.01; Online Figure  IIC and IID). To confirm that QKI expression levels impact the Myocd_v3/Myocd_v1 mRNA balance, we harvested RNA from HITC6 VSMCs cultured in the presence of serum and 3 days after serum withdrawal, which drives these cells toward a contractile phenotype. As a control, we also tested if QKI impacts the Myocd_v4/Myocd_v2 balance; however, we did not observe alternative splicing of Myocd exon 10a, which in the absence of qre proximal to this alternative exon is unlikely ( Figure 5H; bottom) . 31 As shown in Figure 5H I, Schematic of pDup-2a splicing reporters based on Myocd exon 2a. Sequence encoding myocd exon 2a (red box) was inserted into pDup51, which contains sequence encoding exons 1 and 3 from β-globin. The qre in the WTsequence was mutated within exon 2a (yellow box; ACTAA→ACTGA). HEK293s were transfected with depicted constructs and RNA harvested after 24 hours. J, PCR analysis of spliced variants in 2a-wt-qre-and 2a-mut-qre-transfected HEK293s (middle; n=6 for each condition) with quantification of splicing provided to the right. Data are mean±SE. *P<0.05, **P<0.01, ***P<0.001, #P<0.0001. October 12, 2013 triggering the virtually exclusive inclusion of exon 2a in sh-qkI VSMCs (lane 4; 78% Myocd_v3). Given that Myocd_v1 is the primary splice variant expressed in the heart, we sought to determine if QkI-5, QkI-6, and QkI-7 expression levels were increased in the heart as compared with the aorta. As shown in Online Figure IVA , QkI mRNA expression levels are significantly higher in the heart than in the aorta, providing the interesting possibility that QKI protein levels are also involved in regulating Myocd_v3/Myocd_v1 balance in the healthy and diseased heart (n=6 mice).
Finally, to test the role of QKI directly in regulating exon 2a alternative splicing, we generated a splicing reporter construct by replacing exon 2 of the encoded β-hemoglobin (hbb) gene by the genomic sequence encoding myocd exon 2a along with flanking intronic regions (2a-wt-qre). Next, we mutated the qre from ACTAA→ACTGA (2a-mut-qre; Figure 5I ). This mutation was chosen because it maintains the presence of a stop codon in exon 2a, while concomitantly abolishing the capacity of QKI to bind there. 6 Mutation of the qre in exon 2a led to a striking enhancement of exon 2a inclusion ( Figure 5I and 5J). Our findings strongly suggest that QKI regulates the expression and alternative splicing of Myocd.
Myocd_v3 Expression Levels Impact VSMC Contractile Function
To gain insight into the consequences of Myocd pre-mRNA alternative splicing events, we transduced HITA2 VSMCs with lentivirus encoding EGFP, 2 variants of MYOCD_v1 (v1a lacks exon 2a, whereas v1b lacks ATG2 and ATG3 and, therefore, exclusively produces MYOCD_v1), or 2 MYOCD_v3 variants (v3a includes exon 2a, whereas in v3b the first 2 exons are deleted from the encoded cDNA leading exclusively to the production of MYOCD_v3; Figure 6A and see Material and Methods section in the Online Data Supplement). As a vector expression control, total Myocd mRNA levels were significantly increased in all cases as compared with EGFP (primers in common sequence; Online Figure VA; n=3; P<0.001) , whereas exon 2 to 5 expression levels in EGFP-and v3boverexpressing VSMCs were comparable because of the fact that v3b lacks the 5′-primer site ( Figure 6A and Online Figure  VB) . Gel electrophoresis of these mRNA species confirmed that EGFP-, v1a-, and v1b-transduced VSMCs exclusively express Myocd_v1 ( Figure 6B; lanes 1-3) , whereas v3a-overexpression exclusively yields Myocd_v3 ( Figure 6B; lane 4) . Interestingly, transduction of VSMCs with v3b was found to induce expression of endogenous Myocd_v3 ( Figure 6B ; lane 5, upper band).
Subsequent Western blot analysis for HA-tagged MYOCD revealed that overexpression of v3a and v3b in VSMCs increased MYOCD protein expression as compared with v1aand v1b-overexpressing VSMCs ( Figure 6C ). In keeping with literature, both MYOCD_v1 and MYOCD_v3 overexpression potently induced ACTA2 protein expression 32 (Figure 6C ).
To determine if augmentation of MYOCD_v3 could indeed impact VSMC contractility, we seeded EGFP-, v1a-, v1b-, v3a-, and v3b-transduced HITA2 VSMCs on the aforementioned silicone elastomere substrate. Similar to sh-conttransduced HITA2 VSMCs (Figure 4G ), EGFP-transduced VSMCs did not contract the substrate and remained proliferative ( Figure 6D and 6E ; n=3 biological replicates). In contrast, MYOCD_v1a and v1b overexpression induced a low level of contraction and modest proliferation, whereas MYOCD_v3a-and v3b-overexpressing VSMCs displayed both significantly greater cellular contractility and decreased cellular proliferation ( Figure 6D and 6E ). In keeping with literature, we observed modest, yet significant increases in the mRNA levels of contractile apparatus protein as a result of MYOCD_v3 overexpression as compared with MYOCD_ v1 overexpression ( Figure 6F ; n=3 biological replicates). 31 Collectively, these studies suggest that the expression levels of the distinct MYOCD isoforms can indeed influence VSMC contractile function.
Vascular Injury Triggers Myocd Alternative Splicing
It is well established that arterial injury induces VSMC dedifferentiation. 30 To test if this response to arterial injury is associated with a change in the expression levels of Myocd splice variants, apoE -/mice on a Western-type diet underwent wire injury of the left carotid artery. At days 0 (uninjured), 1, 3, 7, 14, 21, and 28, the injured carotid arteries were harvested and mRNA transcript levels of QkI-5, QkI-6, QkI-7, total Myocd, and Myocd_v3/Myocd_v1 mRNA balance were determined (n=4 mice per time point). In keeping with the QkI mRNA expression profile observed after femoral cuff placement in WT and apoE -/mice (Figure 2A and Online Figure IA) , wire injury of the carotid artery resulted in an initial decrease in QkI mRNA expression levels, followed by an increase in qkI mRNA expression levels, with, in particular, a 1.85-fold increase in QkI-6 mRNA levels after 7 days ( Figure 7A ; *P<0.05). Concordantly, Myocd expression was 2.7-fold reduced 7 days after arterial injury and was coupled with a striking shift in expression of Myocd_v3 to Myocd_v1 expression (n=4 mice per time point; 2 mice per time point shown on gel; P<0.05; Figure 7B ). This coexpression of both Myocd_v3 and Myocd_v1 persisted until 21 days post-wire injury, whereas by 28 days the expression of Myocd in carotid arteries had once again reverted to the almost exclusive expression of Myocd_v3 ( Figure 7B ). These findings strongly suggest that QKI-induced alternative splicing of the Myocd pre-mRNA is functionally relevant and generates MYOCD isoforms that are required for both physiological and pathophysiologic situations in the artery wall.
Discussion
The current study demonstrates that QKI expression levels play a central role in the determination of VSMC phenotype. We have identified that QKI is poorly expressed in VSMCs of healthy coronary artery specimens, suggesting that the RNA-binding properties of QKI are repressed in contractile VSMCs. In contrast, our in vivo studies indicate that QKI expression is strongly induced in VSMCs in response to vascular injury, indicating a potential role for QKI in guiding VSMC dedifferentiation, enabling the VSMC to aid in the repair of the damaged portion of the artery wall. Importantly, the unabated proliferation of synthetic VSMCs can lead to rapid luminal narrowing. 12, 15, 32 To this end, the observed decrease in neointima formation in Qk v mice after femoral cuff placement could be the direct result of a decreased capacity to activate gene expression profiles that VSMCs require to proliferate, migrate, and produce ECM production. At present, little is known regarding a role for RNAbinding proteins in regulating VSMC biology in either healthy or diseased situations. HuR, a RNA-binding protein that targets AU-rich regions in 3′-UTRs, has been found to be highly expressed in VSMCs of neointimal lesions where it stabilizes mRNAs encoding cell cycle proteins. 33 In contrast to HuR, recent studies have identified that the majority of qre's in (pre-)mRNAs are localized to intronic regions, 34, 35 whereas recent studies by Hall et al 36 notion, we identified that QKI is a critical post-transcriptional regulator of the Myocd pre-mRNA ( Figure 7C ). This event profoundly impacts MYOCD isoform production, 20, 31, 37 as exon 2a exclusion (Myocd_v1) leads to the generation of a 935-amino acid MYOCD_v1 isoform, whereas exon 2a inclusion (Myocd_v3) leads to the production of a 856-amino acid MYOCD_v3 isoform. Although both isoforms serve as cotranscriptional activators of SRF, 20, 38 the N-terminal portion of MYOCD_v1 confers the protein with the capacity to interact with the myocyte enhancing factor 2 (MEF2) family of transcription factors and encodes a RPEL domain responsible for the interaction with G-actin. 20 Evidence that the QKI-mediated alternative splicing of the Myocd pre-mRNA is physiologically relevent can be derived from the fact that QKI is virtually absent in VSMCs of the healthy artery wall, where Myocd is highly expressed and almost exclusively present as Myocd_v3 splice variant ( Figure 7C ). It is well established that injury to the artery wall triggers VSMC dedifferentiation. 10, 22, 30, 32 We identified that this event is tightly coupled with the dynamic modulation of QKI expression, and that the differential expression of the distinct QKI isoforms induces the enrichment of the Myocd_v1 splice variant in proliferative VSMCs. Here, we hypothesize that alterations in the Myocd splice variant balance are part of the VSMC-mediated response to vascular injury, possibly enhancing the expression of MEF2 target genes ( Figure 7C ). Importantly, Firulli et al 39 have previously identified that MEF2A, MEF2B, and MEF2D are abundantly expressed in neointimal VSMCs of rat restenotic tissue, whereas Creemers et al 20 identified that MEF2 dose-dependently titrates MYOCD_v1 protein from interaction with SRF. As such, a reduction in Myocd expression coupled with a decreased interaction with SRF could be required to activate gene expression profiles that drive arterial repair. Importantly, our data also suggest that VSMCs preferentially express MYOCD_v3 protein, because VSMCs expressing equivalent levels of the Myocd_v1 and Myocd_v3 splice variants expressed markedly more MYOCD_v3 protein, indicating that QKI-mediated alternative splicing of Myocd exon 2a plays a role in regulating MYOCD protein abundance.
SMCs also serve critical roles in the physiological functioning of the intestines, testis, uterus, and urinary bladder. Interestingly, QKI is abundantly expressed in these tissues, 40 providing the interesting possibility that, similar to the artery wall, alterations in QKI expression levels could play a regulatory role in pathological complications in these tissues, such as uterine leiomyoma formation, 41 epididymal hyperplasia, 42 and bladder dysfunction. 43, 44 In conclusion, our findings imply that QKI is not exclusively associated with neural development and disease, but that QKI is in fact a critical regulator of the functional plasticity that is required for VSMC function under both physiological and pathophysiological conditions.
What Is Known?
• In response to vascular injury, vascular smooth muscle cells (VSMCs) of the artery wall aid in the repair of the damaged artery by adopting a proliferative phenotype. • To avoid an excessive reparative response, VSMCs must revert to the contractile phenotype. • This process requires myocardin to trigger a gene expression profile that restores physiological VSMC functioning.
What New Information Does This Article Contribute?
• Vascular injury induces the expression of the RNA-binding protein Quaking (QKI) in VSMCs.
• QKI regulates VSMC phenotype by modulating the expression and alternative splicing of the myocardin pre-mRNA. • Targeted reduction of QKI drives VSMCs to the contractile phenotype in vitro and reduces injury-induced neointima formation in vivo.
Despite the fact that RNA-binding proteins mediate alternative splicing events, their role in the vasculature, and in particular the VSMCmediated response to vascular injury, is poorly understood. Here, we report that the RNA-binding protein QKI influences VSMC phenotype by post-transcriptionally regulating myocardin activity. By regulating a key splicing event in the myocardin pre-mRNA, we propose that QKI expression levels determine whether VSMCs will participate in vessel repair after injury or maintain the vascular tone.
Novelty and Significance
